Reports and Insights (R&I) has published a new report titled, “Hemodialysis Machines Market: Opportunity Analysis and Future Assessment 2020 to 2028”
Global Hemodialysis Machines Market, by Machine Type (Clinical Units, Portable/Home use Machines), By End Users (Hospitals, Clinics, Dialysis Centers, others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2019 and 2027.
As per the report, the rapidly growing prevalence of end-stage renal disease (ESRD), the expanding aging population, technological advances in hemodialysis equipment, are some of the factors pushing the hemodialysis machines market. In the United States, the incidence of ESRD is increasing. Fortunately, both mortality among dialysis patients and the rate at which ESRD has been increasing over the past decade are declining. According to the Center for Disease Control and Prevention (CDC), 726,331 patients in the U.S. being treated with ESRD received hemodialysis, in 2016.
The prevalence of dialysis treatment was found to be 1,553 per million. Although the incidence of ESRD is decreasing, the prevalence of ESRD has more than doubled in the last 25 years. As per the NHS, U.K., over 1.8 million people in England are suffering from chronic kidney disease. In addition, there are thought to be around a million people who have the condition but are undiagnosed. Hemodialysis was first introduced in 1960 and since then the market has witnessed tremendous advancements in hemodialysis techniques and hemodialysis machines. One such development is the introduction of portable hemodialysis machines, which are specially designed for home use or during traveling. These portable dialysis machines have considerably improved the quality of life of patients with ESRD.
Furthermore, Reports and Insights (R&I) Study identifies that the NHS in England spent an estimated £1.45 billion on chronic kidney disease (CKD), equivalent to £1 in every £77 of NHS expenditure. The direct and indirect expenditure on hemodialysis was found to be £505m. Approximately 18,191 patients underwent hemodialysis in England. Hemodialysis technology is rapidly being changed. The hemodialysis technology currently in development is aimed at increasing user-friendliness and connectivity to staff.
Besides, many new companies are entering the hemodialysis machines market with their distinguishing technology and innovative machines, which is expected to take the hemodialysis machines market to the next level. For instance, Outset Medical is working on a new hemodialysis machine Tablo, which is designed for simplicity. NxStage Medical is working on a new home hemodialysis machine System One, which offers higher flow rates than offered today. Baxter’s new home hemodialysis machine, VIVIA, is now undergoing U.S. trials. The system is designed to be patient-friendly and will also use the ShareSource connectivity system.
R&I Study identifies some of the key participating players in the hemodialysis machines market globally are Fresenius Medical Care, Baxter International, Becton Dickinson and Company (C.R Bard), NxStage Medical Inc., Asahi Kasei Medical Co. Ltd., Nipro, SWS Medical Group, Quanta Dialysis Technologies, B. Braun, Dialife SA, etc.
About Reports and Insights (R&I):
Reports and Insights (R&I) is committed to provide deep insights that serve as creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Reports and Insights (R&I)
For Sales Queries: email@example.com
For New Topics and Other Info: firstname.lastname@example.org